REGN-5668 |
REGN-5668 |
临床二期 |
Regeneron Pharmaceuticals Inc |
卵巢癌, 腹膜癌, 输卵管癌 |
详情
|
huAR9.6-IRDye800 |
|
|
University Of Nebraska Medical Center |
|
详情
|
Oregovomab |
B43.13 |
临床三期 |
Paladin Pharma |
卵巢癌, 转移性上皮癌, 腹部肿瘤, 卵巢上皮癌, 胰腺癌, 肿瘤, 腹膜癌, 输卵管癌, 腺癌 |
详情
|
JCAR-020 |
JCAR-020 |
临床一期 |
Memorial Sloan Kettering Cancer Center, Juno Therapeutics Inc, Eureka Therapeutics Inc |
实体瘤, 肿瘤 |
详情
|
PRGN-3005 |
PRGN-3005 |
临床一期 |
Precigen Inc |
卵巢癌, 食道癌, 肉瘤, 腹膜癌, 输卵管癌, 非霍奇金淋巴瘤, 宫颈癌 |
详情
|
Ubamatamab |
REGN-4018 |
临床二期 |
Regeneron Pharmaceuticals Inc |
卵巢癌, 腹膜癌, 输卵管癌 |
详情
|
LBL-033 |
LBL-033 |
临床一期 |
南京维立志博生物科技有限公司 |
肿瘤 |
详情
|